Pharma Journalist -

The Alzheimer's Drug Discovery Foundation (ADDF) and Pfizer's Centers for Therapeutic Innovation (CTI) announced they will jointly support a new project that could result in a potential…
Read More...

Takeda Pharmaceutical Company Limited announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for ALUNBRIG® (brigatinib) 180…
Read More...

MiMedx Group, Inc., the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and…
Read More...

Lonza announced that it is acquiring a clinical-stage mammalian manufacturing site in the United States from Shire plc. Financial details of the deal were not disclosed. The…
Read More...

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, and Dimension Therapeutics, Inc. announced…
Read More...

Aytu BioScience, Inc., a specialty life sciences company focused on global commercialization of novel products in the field of urology, announced that the company has entered into a…
Read More...

Gilead Sciences, Inc. announced a new licensing agreement with the Medicines Patent Pool (MPP), a United Nations-backed public health organization, to expand access to bictegravir (BIC)…
Read More...

Pilgrim Quality Solutions announced the validated release of SmartSolve Out Of Specification (OOS) Management. Pilgrim’s out-of-specification software drives consistent OOS…
Read More...

GSK announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Benlysta (belimumab) for the treatment of adult patients with systemic lupus erythematosus…
Read More...

Werum IT Solutions has released a standalone version of its PAS-X KPI software product. PAS-X KPI is the only KPI/OEE tool dedicated solely to the pharmaceutical and…
Read More...